PurMinds Enterprises, Inc. (formerly Pacific Software, Inc.) announced the signing of a collaboration agreement with SpectroChip Inc., a Taiwan-based developer of photonic-chip sensing and portable testing technologies, and Kaohsiung Municipal Siaogang Hospital, operated by Kaohsiung Medical University, to support teaching, research, and clinical validation of point-of-care (POC) diagnostic technologies and testing solutions.
The collaboration brings together SpectroChip's photonic chip-based portable testing technology, PurMinds' SwiftLabTM Platform and precision-medicine solutions, and Siaogang Hospital's clinical research capabilities. The parties intend to establish the joint "PurMinds / SpectroChip Global Clinical Validation Testing Center" for teaching, research, and clinical-validation activities, as a framework for evaluating diagnostic performance, assessing testing workflows, and advancing research into continuously improved POC performance, subject to review by an institutional review board (IRB), institutional approvals and applicable regulatory requirements.
PurMinds' SwiftLabTM Platform is built around a full-spectrum laboratory-grade spectrometer shrunk onto a single, highly advanced photonic chip and housed inside the SpectroCision SPU-D100, a portable reader small enough to carry anywhere. The platform is designed to turn a low-cost lateral-flow cassette from a faint yes-or-no line into a lab-grade quantitative result in five minutes or less, in clinics, pharmacies, community health centers, and at the patient's bedside. Clinical research and performance evaluation are important steps in assessing how diagnostic technologies and testing solutions perform in intended-use settings.
Under the collaboration, the parties will contribute complementary capabilities:
PurMinds will lead the precision-medicine applications, clinical research collaboration, and access to international research and industry resources in its overall global commercialization strategy.
SpectroChip will provide its photonic chip-based testing technology, together with technical documentation, training, and related support.
Siaogang Hospital will provide an institutional setting for approved teaching, research, and clinical-validation activities, including research design, performance evaluation, testing-workflow assessment, and talent development.
Specific research projects will be established through separate written arrangements defining their scope, responsibilities, timelines, funding, and deliverables. Activities involving human participants, specimens, personal data, or medical-device clinical studies will proceed in accordance with applicable ethical, regulatory, and institutional requirements. The designation does not represent the establishment of a separate legal entity or dedicated physical facility.
